KRAS and lung adenocarcinoma: Low expression levels of the 10-gene set were associated with poor survival in lung cancer (lung adenocarcinoma [LUAD]) patients harboring KRAS mutations (P = 0.035), whereas no association was found in wild-type KRAS LUAD patients (P = 0.958) (Figure 10B).